BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 215 filers reported holding BEAM THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $243,672 | -60.0% | 10,400 | -43.5% | 0.00% | – |
| Q1 2024 | $608,531 | +26.8% | 18,418 | +4.5% | 0.00% | – |
| Q4 2023 | $479,862 | +15.0% | 17,629 | +1.6% | 0.00% | – |
| Q3 2023 | $417,147 | -24.6% | 17,345 | +0.1% | 0.00% | – |
| Q2 2023 | $553,218 | +6.9% | 17,326 | +2.5% | 0.00% | – |
| Q1 2023 | $517,631 | -26.5% | 16,905 | -6.1% | 0.00% | -100.0% |
| Q4 2022 | $704,215 | -13.7% | 18,006 | +5.2% | 0.00% | 0.0% |
| Q3 2022 | $816,000 | +19.8% | 17,111 | -2.6% | 0.00% | 0.0% |
| Q2 2022 | $681,000 | -44.4% | 17,573 | -17.8% | 0.00% | 0.0% |
| Q1 2022 | $1,225,000 | -26.9% | 21,368 | +1.7% | 0.00% | 0.0% |
| Q4 2021 | $1,675,000 | -27.8% | 21,017 | -21.1% | 0.00% | -50.0% |
| Q3 2021 | $2,319,000 | -13.8% | 26,649 | +27.6% | 0.00% | 0.0% |
| Q2 2021 | $2,689,000 | +66.2% | 20,892 | +3.3% | 0.00% | +100.0% |
| Q1 2021 | $1,618,000 | -4.7% | 20,218 | -2.7% | 0.00% | 0.0% |
| Q4 2020 | $1,697,000 | – | 20,782 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,346,934 | $74,937,603 | 45.33% |
| HSG Holding Ltd | 796,089 | $25,419,122 | 2.91% |
| Deep Track Capital, LP | 1,317,316 | $42,061,900 | 1.95% |
| Redmile Group, LLC | 1,485,199 | $47,422,404 | 1.82% |
| ARK Investment Management | 8,382,595 | $267,656,246 | 1.77% |
| Casdin Capital, LLC | 570,000 | $18,200,100 | 1.59% |
| Yiheng Capital Management, L.P. | 463,800 | $14,809,134 | 0.80% |
| Temasek Holdings (Private) Ltd | 4,317,789 | $137,867,003 | 0.80% |
| Alphabet Inc. | 321,604 | $10,268,815 | 0.55% |
| FARALLON CAPITAL MANAGEMENT LLC | 3,441,522 | $109,887,797 | 0.55% |